Isthmus Partners LLC Makes New $1.17 Million Investment in Electromed, Inc. $ELMD

Isthmus Partners LLC purchased a new position in Electromed, Inc. (NYSE:ELMD) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 41,544 shares of the company’s stock, valued at approximately $1,173,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Man Group plc acquired a new position in Electromed in the 2nd quarter valued at approximately $1,601,000. Punch & Associates Investment Management Inc. boosted its holdings in Electromed by 20.1% during the first quarter. Punch & Associates Investment Management Inc. now owns 224,520 shares of the company’s stock valued at $5,256,000 after purchasing an additional 37,500 shares in the last quarter. BlackRock Inc. acquired a new stake in Electromed during the second quarter valued at approximately $19,696,000. Hsbc Holdings PLC bought a new stake in shares of Electromed in the 4th quarter valued at approximately $358,000. Finally, Squarepoint Ops LLC bought a new stake in shares of Electromed in the 2nd quarter valued at approximately $825,000. Institutional investors own 40.82% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ELMD. Lake Street Capital increased their target price on Electromed from $36.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, August 26th. Zacks Research downgraded Electromed from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. Finally, Morgan Stanley set a $50.00 price target on Electromed in a research note on Wednesday, August 26th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Electromed presently has an average rating of “Moderate Buy” and an average price target of $43.75.

Electromed Stock Performance

ELMD opened at $26.87 on Friday. The firm’s 50-day simple moving average is $29.77 and its 200-day simple moving average is $33.89. Electromed, Inc. has a twelve month low of $23.01 and a twelve month high of $47.40. The firm has a market cap of $222.67 million, a price-to-earnings ratio of 35.83 and a beta of 0.40.

Electromed Company Profile

Electromed, Inc is a medical device company that develops, manufactures and distributes airway clearance systems. Its products are designed to help loosen and mobilize pulmonary secretions, supporting airway clearance for patients with chronic respiratory conditions.

The company’s principal product is the SmartVest Airway Clearance System, an inflatable vest system that uses high-frequency chest wall oscillation (HFCWO) technology. SmartVest systems are used in the management of conditions such as bronchiectasis, cystic fibrosis, neuromuscular disorders and other diseases associated with impaired mucus clearance.